These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19948206)

  • 21. Analysis of human hematopoietic stem cell populations.
    Murray L; DiGiusto D; Chen B; Chen S; Combs J; Conti A; Galy A; Negrin R; Tricot G; Tsukamoto A
    Blood Cells; 1994; 20(2-3):364-9; discussion 369-70. PubMed ID: 7538340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of in vitro growth of multiple myeloma cells.
    Zlei M; Egert S; Wider D; Ihorst G; Wäsch R; Engelhardt M
    Exp Hematol; 2007 Oct; 35(10):1550-61. PubMed ID: 17889722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells.
    Hogan CJ; Shpall EJ; McNiece I; Keller G
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):236-46. PubMed ID: 9450918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice.
    Novelli EM; Ramírez M; Leung W; Civin CI
    Stem Cells; 1999; 17(5):242-52. PubMed ID: 10527459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138(-) CD34(-) tumor stem-like cells in multiple myeloma-bearing mice.
    Yang C; Wang J; Chen D; Chen J; Xiong F; Zhang H; Zhang Y; Gu N; Dou J
    Int J Nanomedicine; 2013; 8():1439-49. PubMed ID: 23610522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional B7.2 and B7-H2 molecules on myeloma cells are associated with a growth advantage.
    Yamashita T; Tamura H; Satoh C; Shinya E; Takahashi H; Chen L; Kondo A; Tsuji T; Dan K; Ogata K
    Clin Cancer Res; 2009 Feb; 15(3):770-7. PubMed ID: 19188146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The generation and regulation of functional diversity of malignant plasma cells.
    Nadav L; Katz BZ; Baron S; Cohen N; Naparstek E; Geiger B
    Cancer Res; 2006 Sep; 66(17):8608-16. PubMed ID: 16951174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro expanded cells contributing to rapid severe combined immunodeficient repopulation activity are CD34+38-33+90+45RA-.
    Vanheusden K; Van Coppernolle S; De Smedt M; Plum J; Vandekerckhove B
    Stem Cells; 2007 Jan; 25(1):107-14. PubMed ID: 16973833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction with human stromal cells enhances CXCR4 expression and engraftment of cord blood Lin(-)CD34(-) cells.
    Kobune M; Kawano Y; Takahashi S; Takada K; Murase K; Iyama S; Sato T; Takimoto R; Niitsu Y; Kato J
    Exp Hematol; 2008 Sep; 36(9):1121-31. PubMed ID: 18562079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
    Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
    J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
    Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
    Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma.
    Reid S; Yang S; Brown R; Kabani K; Aklilu E; Ho PJ; Woodland N; Joshua D
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 1):e190-6. PubMed ID: 20201998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of clonogenic multiple myeloma cells.
    Matsui W; Huff CA; Wang Q; Malehorn MT; Barber J; Tanhehco Y; Smith BD; Civin CI; Jones RJ
    Blood; 2004 Mar; 103(6):2332-6. PubMed ID: 14630803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.
    Matsui W; Wang Q; Barber JP; Brennan S; Smith BD; Borrello I; McNiece I; Lin L; Ambinder RF; Peacock C; Watkins DN; Huff CA; Jones RJ
    Cancer Res; 2008 Jan; 68(1):190-7. PubMed ID: 18172311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases.
    Pojero F; Flores-Montero J; Sanoja L; Pérez JJ; Puig N; Paiva B; Bottcher S; van Dongen JJ; Orfao A;
    Cytometry B Clin Cytom; 2016 Jan; 90(1):91-100. PubMed ID: 26130131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The phenotypic plasticity of myeloma plasma cells as expressed by dedifferentiation into an immature, resilient, and apoptosis-resistant phenotype.
    Yaccoby S
    Clin Cancer Res; 2005 Nov; 11(21):7599-606. PubMed ID: 16278377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma.
    Alexandrakis MG; Passam FH; Dambaki C; Pappa CA; Stathopoulos EN
    J Clin Pathol; 2004 Aug; 57(8):856-60. PubMed ID: 15280408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sclerostin is overexpressed by plasma cells from multiple myeloma patients.
    Brunetti G; Oranger A; Mori G; Specchia G; Rinaldi E; Curci P; Zallone A; Rizzi R; Grano M; Colucci S
    Ann N Y Acad Sci; 2011 Nov; 1237():19-23. PubMed ID: 22082361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukemic B cells clonally identical to myeloma plasma cells are myelomagenic in NOD/SCID mice.
    Pilarski LM; Seeberger K; Coupland RW; Eshpeter A; Keats JJ; Taylor BJ; Belch AR
    Exp Hematol; 2002 Mar; 30(3):221-8. PubMed ID: 11882359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SCID-rab model: a novel in vivo system for primary human myeloma demonstrating growth of CD138-expressing malignant cells.
    Yata K; Yaccoby S
    Leukemia; 2004 Nov; 18(11):1891-7. PubMed ID: 15385929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.